• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pharmacokinetics of tigecycline in both plasma and sputum in patients with severe pneumonia.

作者信息

Cai Liang, Kong Lingti, Wu Chenchen, Wu Desheng, Wu Xiaofei

机构信息

Department of Emergency Internal Medicine, the First Affiliated Hospital of Bengbu Medical College, Bengbu, China.

Department of Pharmacy, the First Affiliated Hospital of Bengbu Medical College, Bengbu, China.

出版信息

J Glob Antimicrob Resist. 2021 Sep;26:1-3. doi: 10.1016/j.jgar.2021.04.023. Epub 2021 May 19.

DOI:10.1016/j.jgar.2021.04.023
PMID:34020074
Abstract
摘要

相似文献

1
Pharmacokinetics of tigecycline in both plasma and sputum in patients with severe pneumonia.
J Glob Antimicrob Resist. 2021 Sep;26:1-3. doi: 10.1016/j.jgar.2021.04.023. Epub 2021 May 19.
2
A Monte Carlo pharmacokinetic/pharmacodynamic simulation to evaluate the efficacy of minocycline, tigecycline, moxifloxacin, and levofloxacin in the treatment of hospital-acquired pneumonia caused by Stenotrophomonas maltophilia.应用蒙特卡罗药代动力学/药效学模拟评价米诺环素、替加环素、莫西沙星和左氧氟沙星治疗嗜麦芽窄食单胞菌医院获得性肺炎的疗效。
Infect Dis (Lond). 2015;47(12):846-51. doi: 10.3109/23744235.2015.1064542. Epub 2015 Jul 13.
3
Use of Monte Carlo simulation to evaluate the efficacy of tigecycline and minocycline for the treatment of pneumonia due to carbapenemase-producing Klebsiella pneumoniae.利用蒙特卡罗模拟评估替加环素和米诺环素治疗产碳青霉烯酶肺炎克雷伯菌肺炎的疗效。
Infect Dis (Lond). 2018 Jul;50(7):507-513. doi: 10.1080/23744235.2018.1423703. Epub 2018 Jan 9.
4
Population pharmacokinetics and exposure-response analysis of tigecycline in patients with hospital-acquired pneumonia.替加环素在医院获得性肺炎患者中的群体药代动力学和暴露-反应分析。
Br J Clin Pharmacol. 2021 Jul;87(7):2838-2846. doi: 10.1111/bcp.14692. Epub 2021 May 26.
5
Tigecycline population pharmacokinetics in patients with community- or hospital-acquired pneumonia.替加环素治疗社区获得性或医院获得性肺炎患者的群体药代动力学。
Antimicrob Agents Chemother. 2010 Dec;54(12):5180-6. doi: 10.1128/AAC.01414-09. Epub 2010 Oct 4.
6
Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia.比较替加环素与亚胺培南/西司他丁治疗医院获得性肺炎。
Diagn Microbiol Infect Dis. 2010 Oct;68(2):140-51. doi: 10.1016/j.diagmicrobio.2010.05.012.
7
Randomized phase 2 trial to evaluate the clinical efficacy of two high-dosage tigecycline regimens versus imipenem-cilastatin for treatment of hospital-acquired pneumonia.随机 2 期临床试验评估两种高剂量替加环素方案与亚胺培南-西司他丁治疗医院获得性肺炎的临床疗效。
Antimicrob Agents Chemother. 2013 Apr;57(4):1756-62. doi: 10.1128/AAC.01232-12. Epub 2013 Jan 28.
8
Efficacy and Safety of Tigecycline for Patients with Hospital-Acquired Pneumonia.替加环素治疗医院获得性肺炎患者的疗效与安全性
Chemotherapy. 2016;61(6):323-30. doi: 10.1159/000445425. Epub 2016 May 4.
9
Effectiveness of tigecycline-based versus colistin- based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumannii in a critical setting: a matched cohort analysis.在重症环境下，基于替加环素与基于黏菌素的治疗方案对多重耐药鲍曼不动杆菌所致肺炎的治疗效果：一项配对队列分析
BMC Infect Dis. 2014 Feb 24;14:102. doi: 10.1186/1471-2334-14-102.
10
Efficacy and safety of tigecycline monotherapy versus combination therapy for the treatment of hospital-acquired pneumonia (HAP): a meta-analysis of cohort studies.替加环素单药治疗与联合治疗医院获得性肺炎（HAP）的疗效与安全性：队列研究的荟萃分析
J Chemother. 2018 May;30(3):172-178. doi: 10.1080/1120009X.2018.1425279. Epub 2018 Feb 6.

引用本文的文献

1
Synergistic Role of Biofilm-Associated Genes and Efflux Pump Genes in Tigecycline Resistance of Acinetobacter baumannii.生物膜相关基因和外排泵基因在鲍曼不动杆菌替加环素耐药中的协同作用。
Med Sci Monit. 2023 Sep 9;29:e940704. doi: 10.12659/MSM.940704.
2
Tigecycline Pharmacokinetic and Pharmacodynamic Profile in Patients with Chronic Obstructive Pulmonary Disease Exacerbation.替加环素在慢性阻塞性肺疾病急性加重患者中的药代动力学和药效学特征
Antibiotics (Basel). 2023 Feb 2;12(2):307. doi: 10.3390/antibiotics12020307.